Javier de la Rubia (J de la Rubia Comos, J De La Rubia, J De la Rubia Comos, Javier de la Rubia Comos, Javier De La Rubia, Javier De la Rubia)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 51

Top Venues

Cancers

Expert review of hematology

Blood cancer journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Univrsity Hospital Doctor Peset

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Univrsity Hospital Doctor Peset Sep 05 2014

Spain

Head of Department :: Hematology

University Hospital La Fe Apr 04 1987 - Dec 31 1990

Spain

Attending physician :: Hematology

Publications

Inés Gómez Seguí, María Eva Mingot Castellano, Cristina Pascual Izquierdo, Javier de la Rubia
Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons. Expert review of hematology 17 (1-3) (2024)
A Medina-Herrera, I Vazquez, I Cuenca, J M Rosa-Rosa, Beñat Ariceta, C Jimenez, M Fernandez-Mercado, M J Larrayoz, N C Gutierrez, M Fernandez-Guijarro, Verónica González De La Calle, Paula Rodriguez Otero, A Oriol, Laura Rosinol, A Alegre, F Escalante, Javier de la Rubia, A I Teruel, Felipe De Arriba, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, E M Ocio, N Puig, Juan José Lahuerta, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, null null
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood cancer journal 14 (1) (2024)
Inés Gómez Seguí, María Eva Mingot Castellano, Cristina Pascual Izquierdo, Javier de la Rubia
Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons. Expert review of hematology (2024)
A Medina-Herrera, I Vazquez, I Cuenca, J M Rosa-Rosa, Beñat Ariceta, C Jimenez, M Fernandez-Mercado, M J Larrayoz, N C Gutierrez, M Fernandez-Guijarro, Verónica González De La Calle, Paula Rodriguez Otero, A Oriol, Laura Rosinol, A Alegre, F Escalante, Javier de la Rubia, A I Teruel, Felipe De Arriba, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, E M Ocio, N Puig, Juan José Lahuerta, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, null null
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood cancer journal 14 (1) (2024)
Pedro Asensi, I Gómez-Seguí, Juan Montoro Gómez, M Villalba Montaner, Pedro Chorão, Pilar Solves, M Santiago Balsera, P Lloret Madrid, J Solís Ruiz, C Sopeña Pell-Ilderton, D Martínez Campuzano, P Granados Serrano, Juan Eirís, A Louro, P Rebollar, A Perla, R Benavente, Javier de la Rubia, Miguel Angel Sanz, A Balaguer, Jaime Sanz Caballer
Incidence, risk factors and therapy response of acute graft-versus-host disease after myeloablative hematopoietic stem cell transplantation with posttransplant cyclophosphamide. Bone marrow transplantation (2024)
Inés Gómez Seguí, María Eva Mingot Castellano, Cristina Pascual Izquierdo, Javier de la Rubia
Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons. Expert review of hematology 17 (1-3) (2024)
Miguel Angel Sanz, Juan Montoro Gómez, Aitana Balaguer-Roselló, Pedro Chorão, Marta Villalba, Inés Gómez, Pilar Solves, Marta Santiago, Pedro Asensi, Brais Lamas, Ana Bataller, Pablo Granados, Juan Eirís, David Martínez-Campuzano, Pilar Lloret, Alberto Louro, Paula Rebollar, Aurora Perla, Javier de la Rubia, Jaime Sanz Caballer
Longitudinal outcome over four decades of allogeneic stem cell transplantation: a single center experience. Bone marrow transplantation (2024)
A Medina-Herrera, I Vazquez, I Cuenca, J M Rosa-Rosa, Beñat Ariceta, C Jimenez, M Fernandez-Mercado, M J Larrayoz, N C Gutierrez, M Fernandez-Guijarro, Verónica González De La Calle, Paula Rodriguez Otero, A Oriol, Laura Rosinol, A Alegre, F Escalante, Javier de la Rubia, A I Teruel, Felipe De Arriba, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, E M Ocio, N Puig, Juan José Lahuerta, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, null null
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood cancer journal 14 (1) (2024)
Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Paula Rodriguez Otero, Verónica González-Calle, Marta Sonia Gonzalez, Albert Ortiol, Norma C Gutiérrez, Rafael Rios-Tamayo, Laura Rosinol, Miguel Angel Alvarez Rivas, Joan Bargay, Ana Pilar Gonzalez-Rodriguez, Adrian Alegre, Fernando Escalante, María Belén Iñigo Rodríguez, Javier de la Rubia, Ana Isabel Teruel, Felipe De Arriba, Luis Palomera, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, Marta Reinoso-Segura, Aránzazu García Mateo, Enrique María Ocio, Juan José Lahuerta, Noemi Puig, María-Teresa Cedena, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, null null
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Paula Rodriguez Otero, Verónica González-Calle, Marta Sonia Gonzalez, Albert Ortiol, Norma C Gutiérrez, Rafael Rios-Tamayo, Laura Rosinol, Miguel Angel Alvarez Rivas, Joan Bargay, Ana Pilar Gonzalez-Rodriguez, Adrian Alegre, Fernando Escalante, María Belén Iñigo Rodríguez, Javier de la Rubia, Ana Isabel Teruel, Felipe De Arriba, Luis Palomera, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, Marta Reinoso-Segura, Aránzazu García Mateo, Enrique María Ocio, Juan José Lahuerta, Noemi Puig, María-Teresa Cedena, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, null null
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Inés Gómez Seguí, María Eva Mingot Castellano, Cristina Pascual Izquierdo, Javier de la Rubia
Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons. Expert review of hematology (2024)
Inés Gómez-Seguí, Maria Cristina Pascual Izquierdo, Maria-Eva Mingot-Castellano, Javier de la Rubia
An update on the pathogenesis and diagnosis of thrombotic thrombocytopenic purpura. Expert review of hematology (2023)
Inés Gómez-Seguí, Maria Cristina Pascual Izquierdo, Maria-Eva Mingot-Castellano, Javier de la Rubia
An update on the pathogenesis and diagnosis of thrombotic thrombocytopenic purpura. Expert review of hematology 16 (1) (2023)
Pilar Solves, Javier Marco-Ayala, Miguel Angel Sanz, Inés Gómez-Seguí, Aitana Balaguer-Roselló, Ana Facal, Marta Villalba, Juan Montoro, Guillermo F Sanz, Javier de la Rubia, Jaime Sanz
Transfusion Burden in Allogeneic Hematopoietic Stem Cell Transplantation over Time: Experience from a Single Institution. Journal of clinical medicine 12 (10) (2023)
Inés Gómez-Seguí, E Francés Aracil, Maria-Eva Mingot-Castellano, M Vara Pampliega, R Goterris Viciedo, F García Candel, C Pascual Izquierdo, J Del Río Garma, L Guerra Domínguez, I Vicuña Andrés, J Garcia-Arroba Peinado, S Zalba Marcos, J M Vidan Estévez, E González Arias, V Campuzano Saavedra, J M García Gala, S Ortega Sanchez, J Martínez Nieto, L Pardo Gambarte, M Solé Rodríguez, M Fernández-Docampo, L F Avila Idrovo, L Hernández, Joan Cid, Javier de la Rubia, null null
Immune thrombotic thrombocytopenic purpura in older patients: Results from the Spanish TTP Registry (REPTT). British journal of haematology (2023)
Inés Gómez-Seguí, Maria Cristina Pascual Izquierdo, Maria-Eva Mingot-Castellano, Javier de la Rubia
An update on the pathogenesis and diagnosis of thrombotic thrombocytopenic purpura. Expert review of hematology 16 (1) (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikandar Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Javier de la Rubia, Rafael Alonso, María Esther Clavero, Elham Askari, Alfonso García, Cristina Antón, Margarita Fernández, Fernando Escalante, Ana García, Rafael Rios-Tamayo, Venancio Conesa, María Arancha Bermúdez, Beatriz Merchán, Alberto E Velasco, María Jesús Blanchard, Maria Antonia Sampol, Eukene Gainza, Prisma Montserrat Hernández, Adrian Alegre
Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain. Cancers 15 (11) (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikandar Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Álvaro Díaz-González, Elvira Mora, Gayane Avetisyan, Santiago Furió, Rosalía De la Puerta, José Vicente Gil, Alessandro Liquori, Eva Villamón, Carmen García-Hernández, Marta Santiago, Cristian Garcia-Ruiz, Marta Llop, Blanca Ferrer-Lores, Eva Barragán, Silvia García-Palomares, Empar Mayordomo, Irene Luna, Ana Vicente, Lourdes Cordón, Leonor Senent, Alberto Álvarez-Larrán, José Vicente Cervera, Javier de la Rubia, Juan Carlos Carlos Hernández-Boluda, Esperanza Such
Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome Mapping. Cancers 15 (11) (2023)
Inés Gómez-Seguí, Maria Cristina Pascual Izquierdo, Maria-Eva Mingot-Castellano, Javier de la Rubia
An update on the pathogenesis and diagnosis of thrombotic thrombocytopenic purpura. Expert review of hematology 16 (1) (2023)
Inés Gómez-Seguí, Maria Cristina Pascual Izquierdo, Maria-Eva Mingot-Castellano, Javier de la Rubia
An update on the pathogenesis and diagnosis of thrombotic thrombocytopenic purpura. Expert review of hematology 16 (1) (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikandar Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Blanca Boluda, Antonio Solana-Altabella, Isabel Cano, David Martínez-Cuadrón, Evelyn Acuña-Cruz, Laura Torres-Miñana, Rebeca Rodríguez-Veiga, Irene Navarro-Vicente, David Martínez-Campuzano, Raquel García-Ruiz, Pilar Lloret, Pedro Asensi, Ana Osa-Sáez, Jaume Aguero, María Rodríguez-Serrano, Francisco Buendía-Fuentes, Juan Eduardo Megías-Vericat, Beatriz Martín-Herreros, Eva Barragán, Claudia Sargas, Maribel Salas, Margaret Wooddell, Charles Dharmani, Miguel Angel Sanz, Javier de la Rubia, Pau Montesinos
Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia. Cancers 15 (8) (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikandar Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Blanca Boluda, Antonio Solana-Altabella, Isabel Cano, David Martínez-Cuadrón, Evelyn Acuña-Cruz, Laura Torres-Miñana, Rebeca Rodríguez-Veiga, Irene Navarro-Vicente, David Martínez-Campuzano, Raquel García-Ruiz, Pilar Lloret, Pedro Asensi, Ana Osa-Sáez, Jaume Aguero, María Rodríguez-Serrano, Francisco Buendía-Fuentes, Juan Eduardo Megías-Vericat, Beatriz Martín-Herreros, Eva Barragán, Claudia Sargas, Maribel Salas, Margaret Wooddell, Charles Dharmani, Miguel Angel Sanz, Javier de la Rubia, Pau Montesinos
Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia. Cancers 15 (8) (2023)
Leire Burgos, Luis Esteban Tamariz-Amador, Noemi Puig, María-Teresa Cedena, Camilla Guerrero, Tomas Jelinek, Sarah Johnson, Paolo Milani, Lourdes Cordon, Jose J Perez, Marta Lasa, Rosalinda Termini, Albert Ortiol, Miguel-Teodoro T Hernandez Garcia, Luis Palomera, Rafael Martinez-Martinez, Javier de la Rubia, Felipe de Arriba, Rafael Rios-Tamayo, Maria-Esther Gonzalez, Mercedes Gironella, Valentín Cabañas, Maria Casanova, Isabel Krsnik, Albert Perez-Montaña, Verónica González De La Calle, Paula Rodriguez Otero, Vladimir Maisnar, Roman Hájek, Frits Van Rhee, Victor Jimenez-Zepeda, Giovanni Palladini, Giampaolo Merlini, Alberto Orfao, Javier de la Cruz, Joaquin Martinez Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Juan José Lahuerta, null null
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Noemí Puig, María-Teresa Contreras, Cristina Agulló, Joaquin Martinez Lopez, Albert Ortiol, María-Jesús Blanchard, Rafael Rios-Tamayo, Jesús Martín, María-Belén Iñigo, Anna Sureda, Miguel-Teodoro T Hernandez Garcia, Javier de la Rubia, Verónica González De La Calle, Isabel Krsnik, Valentín Cabañas, Luis Palomera, José María M Moraleda, Joan Bargay, María-Teresa Cedena, Juan José Lahuerta, Laura Rosiñol, Joan Bladé, Jesús San F Miguel, Juan-José Lahuerta, Maria-Victoria Mateos-Manteca
Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma. Blood advances 6 (11) (2022)
Juan-José Garcés, María-Teresa Cedena, Noemi Puig, Leire Burgos, Jose J Perez, Lourdes Cordon, Juan A Flores-Montero, Luzalba Sanoja-Flores, María-José Calasanz, Albert Ortiol, María-Jesús Blanchard, Rafael Rios-Tamayo, Jesús Martín-Sánchez, Rafael Martínez-Martinez, Joan Bargay, Anna Sureda, Javier de la Rubia, Miguel-Teodoro T Hernandez Garcia, Paula Rodriguez Otero, Javier de la Cruz, Alberto Orfao, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Jesús San F Miguel, Juan José Lahuerta
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Juan Manuel Rosa-Rosa, Isabel Cuenca, Alejandro Medina, Iria Vazquez, Andrea Sánchez-delaCruz, Natalia Buenache, Ricardo Sanchez, Cristina Jiménez, Laura Rosinol, Norma C Gutiérrez, Yanira Ruiz-Heredia, Santiago Barrio, Albert Oriol, Maria-Luisa Martin-Ramos, María-Jesús Blanchard, Rosa María Ayala, Rafael Ríos-Tamayo, Anna Sureda, Miguel-Teodoro Hernández, Javier de la Rubia, Gorka Alkorta-Aranburu, Xabier Agirre, Joan Bladé, Maria-Victoria Mateos-Manteca, Juan-José Lahuerta, Jesús F San-Miguel, María-José Calasanz, Miriam Santero, Joaquín Martínez-Lopez
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial. Cancers 14 (20) (2022)
Felipe de Arriba de la Fuente, Carmen Montes Gaisán, Javier de la Rubia
How to Manage Patients with Lenalidomide-Refractory Multiple Myeloma. Cancers 15 (1) (2022)
Adrián Mosquera Orgueira, Marta Sonia González Pérez, Jose Diaz Arias, Laura Rosinol, Albert Ortiol, Ana Isabel Teruel, Joaquin Martinez Lopez, Luis Palomera, Miquel Granell, Maria Jesus Blanchard, Javier de la Rubia, Ana López de la Guia, Rafael Rios-Tamayo, Anna Sureda, Miguel-Teodoro T Hernandez Garcia, Enrique Bengoechea, María José Calasanz, Norma Gutierrez, Maria Luis Martin, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, null null
Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group. Blood cancer journal 12 (4) (2022)
Maria Cristina Pascual Izquierdo, Maria-Eva Mingot-Castellano, Ana Esther Kerguelen Fuentes, José García-Arroba Peinado, Joan Cid, Moraima Jiménez, David Valcarcel, Ines Gomez-Segui, Javier de la Rubia, Paz Martin, Rosa Goterris, Luis M Hernández-Mateo, Inmaculada Tallón Ruiz, Sara Varea, Marta Fernández-Docampp, Nadia García-Muñoz, Míriam Vara, Miguel Fernández Zarzoso, Faustino García-Candel, María Liz Paciello, Irene García García, Saioa Zalba, Verónica Campuzano Saavedra, Jose Maria Garcia-Gala, Julia Vidan, Gemma Moreno, Jose Luis Lopez Lorenzo, Elena González Arias, Carmen Freiría, María Solé, Laura Francisca Ávila Idrovo, José Carlos Hernández Castellet, Naylen Cruz, Esperanza Lavilla-Rubira, Albert Pérez-Montaña, Jon Ander Atucha, María Esperanza Moreno Beltrán, Juan-Ramón Romero Macías, Ramon Salinas Argente, Julio Del Rio-Garma
Real-world effectiveness of caplacizumab vs standard of care in immune thrombotic thrombocytopenic purpura. Blood advances (2022)
Inés Gómez-Seguí, Cristina Pascual Izquierdo, Maria-Eva Mingot-Castellano, Javier de la Rubia
An update on the pathogenesis and diagnosis of thrombotic thrombocytopenic purpura. Expert review of hematology (2022)
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, Blanca Boluda, Isabel Cano, Evelyn Acuña-Cruz, Rebeca Rodríguez-Veiga, Laura Torres-Miñana, Claudia Sargas, Miguel Angel Sanz, Carmela Borrell-García, Eduardo López-Briz, José Luis Poveda-Andrés, Javier de la Rubia, Pau Montesinos, David Martínez-Cuadrón
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study. Cancers 14 (8) (2022)
Rosalinda Termini, David Zihala, Evangelos Terpos, Albert Perez-Montaña, Tomas Jelinek, Marc-Steffen Raab, Niels Weinhold, Elias Karl Mai, Anna Luise Grab, Jill Corre, François Vergez, Antonio Sacco, Marco Chiarini, Viviana Giustini, Alessandra Tucci, Sara Rodriguez, Cristina Moreno, Cristina Perez, Catarina Maia, Esperanza Martin-Sanchez, Camilla Guerrero, Cirino Botta, Juan-José Garcés, Aitziber Lopez, Luis Esteban Tamariz-Amador, Felipe Prosper, Joan Bargay, Maria-Elena Cabezudo, Enrique María Ocio, Roman Hájek, Joaquin Martinez Lopez, Fernando Solano, Rebeca Iglesias, Artur Paiva, Catarina Geraldes, Helena Vitoria, Clara Gomez, Felipe De Arriba, Heinz Ludwig, Antoni Garcia-Guiñon, María Casanova, Adrian Alegre, Valentín Cabañas, Maialen Sirvent, Albert Ortiol, Javier de la Rubia, Jose-Ángel Hernández-Rivas, Luis Palomera, Maria Sarasa, Pablo Rios, Noemi Puig, Maria-Victoria Mateos-Manteca, Juan A Flores-Montero, Alberto Orfao, Hartmut Goldschmidt, Herve Avet-Loiseau, Aldo M Roccaro, Jesús San F Miguel, Juan José Lahuerta, null null
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Felipe de Arriba de la Fuente, Carmen Montes Gaisán, Javier de la Rubia
How to Manage Patients with Lenalidomide-Refractory Multiple Myeloma. Cancers 15 (1) (2022)
Felipe de Arriba de la Fuente, Carmen Montes Gaisán, Javier de la Rubia
How to Manage Patients with Lenalidomide-Refractory Multiple Myeloma. Cancers 15 (1) (2022)
Ana Villalba, Ana Pilar Gonzalez-Rodriguez, Javier Arzuaga-Mendez, Noemí Puig, Mario Arnao, José María Arguiñano, María Jimenez, Marta Canet, Ana I Teruel, María Sola, Francisco J Díaz, Cristina Encinas, Antonio Garcia, Laura Rosinol, Alexia Suárez, Marta Sonia Gonzalez, Isabel Izquierdo, Miguel Teodoro Hernández, María Stefania Infante, María José Sánchez, Maria Antonia Sampol, Javier de la Rubia
Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics. A retrospective, open-label study of the PETHEMA/Spanish Myeloma Group (GEM). Leukemia & lymphoma (2022)
Lorenzo Lazzari, Aitana Balaguer-Roselló, Juan Montoro Gómez, Raffaella Greco, Rafael Hernani, Maria Teresa Lupo Stanghellini, Marta Villalba, Fabio Giglio, Ana Facal, Francesca Lorentino, Manuel Guerreiro, Alessandro Bruno, Ariadna Pérez, Elisabetta Xue, Daniela Clerici, Simona Piemontese, José Luis Piñana, Miguel Angel Sanz, Carlos Solano, Javier de la Rubia, Fabio Ciceri, Jacopo Peccatori, Jaime Sanz Caballer
Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia. Bone marrow transplantation 57 (9) (2022)
Mariam Ibáñez, Esperanza Such, Alessandro Liquori, Gayane Avestisyan, Rafael Andreu, Ana Vicente, María José Macián, Mari Carmen Melendez, Mireya Morote-Faubel, Pedro Asensi, María Pilar Lloret, Isidro Jarque, Isabel Picón, Alejandro Pacios, Eva Donato, Carmen Mas-Ochoa, Carmen Alonso, Carolina Cañigral, Amparo Sempere, Samuel Romero, Marta Santiago, Guillermo F Sanz, Javier de la Rubia, Leonor Senent, Irene Luna
Panel Sequencing for Clinically Oriented Variant Screening and Copy Number Detection in Chronic Lymphocytic Leukemia Patients. Diagnostics (Basel, Switzerland) 12 (4) (2022)
Marie Anne Scully, Javier de la Rubia, Katerina Pavenski, Ara Metjian, Paul N Knöbl, Flora Peyvandi, Spero R Cataland, Paul Coppo, Johanna A Kremer Hovinga, Jessica Minkue Mi Edou, Rui de Passos Sousa, Filip Callewaert, Sriya Gunawardena, Julie Lin
Long-term follow-up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post-HERCULES study. Journal of thrombosis and haemostasis : JTH 20 (12) (2022)
Cristina Encinas, José-Ángel Hernandez-Rivas, Albert Ortiol, Laura Rosiñol, María-Jesús Blanchard, José-María Bellón, Miriam Santero, Javier de la Rubia, Ana López de la Guía, Ana Jímenez-Ubieto, Isidro Jarque, Belén Iñigo, Victoria Dourdil, Felipe De Arriba, Clara Cuéllar Pérez-Ávila, Yolanda Gonzalez, Miguel-Teodoro Hernández, Joan Bargay, Miquel Granell, Paula Rodríguez-Otero, Maialen Silvent, Carmen Cabrera, Rafael Rios, Adrian Alegre, Mercedes Gironella, Marta-Sonia Gonzalez, Anna Sureda, Maria Antonia Sampol, Enrique M Ocio, Isabel Krsnik, Antonio García, Aránzazu García-Mateo, Joan-Alfons Soler, Jesús Martín-Sánchez, José-María Arguiñano, Maria-Victoria Mateos-Manteca, Joan Bladé, Jesús San F Miguel, Juan-José Lahuerta, Joaquin Martinez Lopez, null null
A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma. Blood cancer journal 12 (4) (2022)
María José Cejalvo, Gabriela Bustamante, Esther González, Judith Vázquez-Álvarez, Ricarda García, Ángel Ramírez-Payer, Ernesto Pérez-Persona, Eugenia Abella, Sebastián Garzón, Antoni García, Isidro Jarque, Marta Sonia González, Antonia Sampol, Cristina Motlló, Josep María Martí, Magdalena Alcalá, Rafael Duro, Yolanda González, José Luis Sastre, Josep Sarrà, Giselle Lostaunau, Rocío López, Javier de la Rubia
Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma. Annals of hematology 100 (7) (2021)
Daniel Alameda, Ibai Goicoechea, Marco Vicari, Elena Arriazu, Alice Nevone, Sara Rodriguez, Marta Lasa, Noemi Puig, Maria Teresa Cedena, Diego Alignani, Sonia Garate, David Lara-Astiaso, Amaia Vilas-Zornoza, Sarai Sarvide, Enrique María Ocio, Ramon Lecumberri, Alfonso Garcia de Coca, Jorge Labrador, Maria-Esther Gonzalez, Luis Palomera, Mercedes Gironella, Valentín Cabañas, Maria Casanova, Albert Ortiol, Isabel Krsnik, Albert Perez-Montaña, Javier de la Rubia, José Enrique de la Puerta, Felipe de Arriba, Vito Michele Fazio, Joaquin Martinez Lopez, Juan-José Lahuerta, Maria-Victoria Mateos-Manteca, Maria-Dolores Odero, Felipe Prosper, Assaf Weiner, Ido Amit, Mario Nuvolone, Jesús San F Miguel, Juan José Lahuerta
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development. Blood 138 (17) (2021)
Ana Jiménez-Ubieto, Juan José Lahuerta, Noemi Puig, María-Teresa Cedena, Joaquin Martinez Lopez, Albert Ortiol, María-Jesús Blanchard, Rafael Ríos, Jesús Martin, Rafael Martínez, Anna Sureda, Miguel-Teodoro T Hernandez Garcia, Javier de la Rubia, Isabel Krsnik, Valentín Cabañas, Luis Palomera, José María Sánchez-Pina, Joan Bargay, Maria-Victoria Mateos-Manteca, Laura Rosinol, Joan Blade, Jesús San F Miguel, Juan-José Lahuerta, null null
Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change? Blood 138 (19) (2021)
Mario A Legarda, María J Cejalvo, Javier de la Rubia
Recent Advances in the Treatment of Patients with Multiple Myeloma. Cancers 12 (12) (2020)
Enrique María Ocio, Cristina Motlló, Paula Rodríguez-Otero, Joaquin Martinez-Lopez, Mª José Cejalvo, Jesús Martín-Sánchez, Joan Bladé, Mª Dolores García-Malo, Mª Victoria Dourdil, Aránzazu García-Mateo, Felipe de Arriba, Ramón García-Sanz, Javier de la Rubia, Albert Oriol, Juan-José Lahuerta, Jesús San F Miguel, Maria-Victoria Mateos-Manteca
Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1-acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group. British journal of haematology 192 (3) (2020)
Noemí Puig, Luis-Antonio Corchete, José J Pérez-Morán, Julio Dávila-Valls, Teresa Paíno, Javier de la Rubia, Albert Ortiol, Jesús Martín-Sánchez, Felipe de Arriba, Joan Bladé, María-Jesús Blanchard, Verónica González De La Calle, Miriam Santero, Bruno Paiva, Juan-José Lahuerta, Jesús F San-Miguel, Maria-Victoria Mateos-Manteca, Enrique María Ocio
Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial. Cancers 12 (12) (2020)
M Blanes, J I Lorenzo, P Ribas, A Jiménez, J D González, M J Cejalvo, C Solano, A Alegre, Javier de la Rubia
Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma. Annals of hematology 98 (8) (2019)
María J Cejalvo, Mario A Legarda, Eugenia Abella, Elena Cabezudo, Cristina Encinas, Ana García-Feria, Mercedes Gironella, Belén Iñigo, Jesús Martín, Paz Ribas, Mª Ángeles Ruíz, Yolanda González, Isabel Vicuña, Ángel Ramírez, Pascual Fernández, Javier de la Rubia
Single-agent daratumumab in patients with relapsed and refractory multiple myeloma requiring dialysis: results of a Spanish retrospective, multicentre study. British journal of haematology 190 (5) (2019)

Javier de la Rubia.css-eqlu8i{font-size:small;padding-left:4px;} (J de la Rubia Comos, J De La Rubia, J De la Rubia Comos, Javier de la Rubia Comos, Javier De La Rubia, Javier De la Rubia)

Publication Activity (10 Years)

Top Topics

Top Venues

Javier de la Rubia (J de la Rubia Comos, J De La Rubia, J De la Rubia Comos, Javier de la Rubia Comos, Javier De La Rubia, Javier De la Rubia)